UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

Cross-sectional survey on defensive practices and defensive behaviours among Israeli psychiatrists

BMJ open, 2017-03, Vol.7 (3), p.e014153-e014153

2017

Volltextzugriff (PDF)

Elevated brain-derived cell-free DNA among patients with first psychotic episode - a proof-of-concept study

eLife, 2022-06, Vol.11

2022

Volltextzugriff (PDF)

Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition

Psychiatric genetics, 2012-08, Vol.22 (4), p.168-176

2012

Volltextzugriff (PDF)

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

The Lancet (British edition), 2016-10, Vol.388 (10056), p.2153-2163

2016

Volltextzugriff (PDF)

Charging Electric Vehicles in the Smart City: A Survey of Economy-Driven Approaches

IEEE transactions on intelligent transportation systems, 2016-08, Vol.17 (8), p.2089-2106

2016

Volltextzugriff (PDF)

A CoAP-Based Network Access Authentication Service for Low-Power Wide Area Networks: LO-CoAP-EAP

Sensors (Basel, Switzerland), 2017-11, Vol.17 (11), p.2646

2017

Volltextzugriff (PDF)

Chemical Element Profiling in the Sera and Brain of Bipolar Disorders Patients and Healthy Controls

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14362

2022

Volltextzugriff (PDF)

Integrating Cellular Networks, Smart Grid, and Renewable Energy: Analysis, Architecture, and Challenges

IEEE access, 2015-01, Vol.3, p.2755-2770

2015

Volltextzugriff (PDF)

Human dirofilariasis in Bulgaria between 2009 and 2018

Helminthologia, 2019-09, Vol.56 (3), p.247-251

2019

Volltextzugriff (PDF)

Vanadium in Bipolar Disorders-Reviving an Old Hypothesis

International journal of molecular sciences, 2022-11, Vol.23 (22), p.13901

2022

Volltextzugriff (PDF)

RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma

Annals of oncology, 2015-07, Vol.26 (7), p.1378-1384

2015

Volltextzugriff (PDF)

Involvement of the Na + , K + -ATPase α1 Isoform and Endogenous Cardiac Steroids in Depression- and Manic-like Behaviors

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1644

2024

Volltextzugriff (PDF)

Neonatal urinoma associated with ascites in a newborn with a solitary kidney

Folia medica (Plovdiv), 2022-12, Vol.64 (6), p.998-1002

2022

Volltextzugriff (PDF)

Initial experience in the field of pediatric percutaneous nephrolitholapaxia in Bulgaria

Folia medica (Plovdiv), 2021-06, Vol.63 (3), p.348-354

2021

Volltextzugriff (PDF)

Enabling Extremely Energy-Efficient End-to-End Secure Communications for Smart Metering Internet of Things Applications Using Static Context Header Compression

Applied sciences, 2023-11, Vol.13 (21), p.11921

2023

Volltextzugriff (PDF)

Well-founded and stable semantics of logic programs with aggregates

Theory and practice of logic programming, 2007-05, Vol.7 (3), p.301-353

2007

Volltextzugriff (PDF)

A rare case of congenital anterior urethral diverticulum in a two-year-old boy

Urology case reports, 2021-11, Vol.39, p.101768, Article 101768

2021

Volltextzugriff (PDF)

Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3

Epilepsia (Copenhagen), 2021-12, Vol.62 (12), p.3029-3041

2021

Volltextzugriff (PDF)

Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

The lancet child & adolescent health, 2018-07, Vol.2 (7), p.495-504

2018

Volltextzugriff (PDF)

Epididymal Dirofilariasis in a Child: First Case Report from Bulgaria

Medical principles and practice, 2019-04, Vol.28 (1), p.96-98

2019

Volltextzugriff (PDF)

NATALEE: Phase III study of ribociclib (RIBO) + endocrine therapy (ET) as adjuvant treatment in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early breast cancer (EBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS597-TPS597

2019

Volltextzugriff (PDF)

Reducing the Energy Footprint of Cellular Networks with Delay-Tolerant Users

IEEE systems journal, 2017-06, Vol.11 (2), p.729-739

2017

Volltextzugriff (PDF)

Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial

Neurology. Clinical practice, 2018-10, Vol.8 (5), p.412-420

2018

Volltextzugriff (PDF)

Дисбалансите в сферата на недвижимите имоти

НЕДВИЖИМИ ИМОТИ & БИЗНЕС, 2021, Vol.V (3), p.148-153

Pelov, Tihomir

2021

Volltextzugriff (PDF)

Sustained reduction in seizure frequency with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC) in children under 6 years of age: Results from the phase 3 EXIST-3 extension phase

European journal of paediatric neurology, 2017-06, Vol.21, p.e33-e33

2017

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(61)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Computer Science
(27)
Humans
(26)
Technology
(22)
Networking And Internet Architecture
(21)
Female
(16)
Engineering
(15)
Life Sciences & Biomedicine
(15)
Male
(15)
Adult
(13)
Engineering, Electrical & Electronic
(13)
Middle Aged
(13)
Multimedia
(11)
Batteries
(9)
Telecommunications
(9)
Energy Consumption
(8)
Smart Grids
(8)
Base Stations
(7)
Delays
(7)
Energy Efficiency
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cross-sectional survey on defensive practices and defensive behaviours among Israeli psychiatrists

Elevated brain-derived cell-free DNA among patients with first psychotic episode - a proof-of-concept study

Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Charging Electric Vehicles in the Smart City: A Survey of Economy-Driven Approaches

A CoAP-Based Network Access Authentication Service for Low-Power Wide Area Networks: LO-CoAP-EAP

Chemical Element Profiling in the Sera and Brain of Bipolar Disorders Patients and Healthy Controls

Integrating Cellular Networks, Smart Grid, and Renewable Energy: Analysis, Architecture, and Challenges

Human dirofilariasis in Bulgaria between 2009 and 2018

Vanadium in Bipolar Disorders-Reviving an Old Hypothesis

RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma

Involvement of the Na + , K + -ATPase α1 Isoform and Endogenous Cardiac Steroids in Depression- and Manic-like Behaviors

Neonatal urinoma associated with ascites in a newborn with a solitary kidney

Initial experience in the field of pediatric percutaneous nephrolitholapaxia in Bulgaria

Enabling Extremely Energy-Efficient End-to-End Secure Communications for Smart Metering Internet of Things Applications Using Static Context Header Compression

Well-founded and stable semantics of logic programs with aggregates

A rare case of congenital anterior urethral diverticulum in a two-year-old boy

Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3

Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

Epididymal Dirofilariasis in a Child: First Case Report from Bulgaria

NATALEE: Phase III study of ribociclib (RIBO) + endocrine therapy (ET) as adjuvant treatment in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early breast cancer (EBC)

Reducing the Energy Footprint of Cellular Networks with Delay-Tolerant Users

Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial

Дисбалансите в сферата на недвижимите имоти

Sustained reduction in seizure frequency with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC) in children under 6 years of age: Results from the phase 3 EXIST-3 extension phase

Suchergebnisse filtern